Home > Insider Trading > Filing (0001144204-18-063613)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1425205	Iovance Biotherapeutics Inc.	IOVA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1423102	P. Wayne Rothbaum	999 Skyway Road, Suite 150 San Carlos CA 94070		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-04	921,053	$10.31	6,767,333	No	4	P	Indirect	By Quogue Capital LLC
Common Stock	Acquisiton	2018-12-06	300,000	$9.86	7,067,333	No	4	P	Indirect	By Quogue Capital LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Quogue Capital LLC
No	4	P	Indirect	By Quogue Capital LLC

Footnotes

The price reported in Column 4 is an average price. These shares were purchased by Quogue Capital LLC in multiple transactions at prices ranging from $9.88 to $10.51, inclusive. The reporting person undertakes to provide to Iovance Biotherapeutics, Inc., the staff of the Securities and Exchange Commission, and others pursuant to applicable securities laws, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The price reported in Column 4 is an average price. These shares were purchased by Quogue Capital LLC in multiple transactions at prices ranging from $9.40 to $10.07, inclusive.
The reporting person is the managing member of Quogue Capital LLC and so may be deemed to beneficially own such shares of common stock. The numbers reported in column 6 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock held by Quogue Capital LLC.